Trends of Patients' Preferences in the Management of First and Early Second Trimester Pregnancy Loss Towards the Choice of Medical or Surgical Termination of Pregnancy in a Tertiary Care Center in Oman

Al-Dughaishi, Tamima; Hamed Al-Jabri, Mussab; Al-Haddabi, Amjad; Gowri, Vaidyanathan

Trends of Patients' Preferences in the Management of First and Early Second Trimester Pregnancy Loss Towards the Choice of Medical or Surgical Termination of Pregnancy in a Tertiary Care Center in Oman

Authors

Tamima Al-Dughaishi

Mussab Hamed Al-Jabri

Amjad Al-Haddabi

Vaidyanathan Gowri

Sultan Qaboos University and Hospital, Muscat, Oman

Abstract

Background: This study aimed to find out the patients preference towards the managementof pregnancy loss to either Misoprostol or dilatation and evacuation or curettage (D&C) in two different study periods. Methods: Retrospective chart review study included a total of 411 patients. The first study period was January to December 2010 and the second study period was January to December 2014. All patients were managed in Sultan Qaboos University Hospital of Oman. Results: Misoprostol was more preferable than dilatation and curettage D&C in both 2010 and 2014, with percentages of 79.30% and 69.57%, respectively. There was a slight increase in the preference toward D&C in 2014. There was a slight increase in the preference toward D&C with older age group as well as in patients with history of miscarriages. Conclusion: In comparison between 2010 and 2014 data, there was no significant change in patients’ preference. There was a slight increase in the preference toward D&C in the older age group and in patients with previous history of abortion in both years.

Keywords

abortion

Miscarriage

misoprostol

Parity

Trends

Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30(3):495-8.

Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. New Engl J Med. 1988;319(4):189-94.

Symonds IM, Arulkumaran S, Symonds EM. 5th ed. Essential obstetrics and gynecology. London: Edinburgh: Churchill Livingstone/Elsevier; 2013. p. 277-82.

Niinimäki M, Karinen P, Hartikainen AL, Pouta A. Treating miscarriages: a randomised study of cost-effectiveness in medical or surgical choice. BJOG. 2009;116(7):984-90.

World Health Organization (WHO) [Internet]. Geneva: WHO headquarters; c 2019. WHO Model List of Essential Medicines; 2017 [cited 2018 Jun 12]. Available from: http://www.who.int/medicines/publications/essentialmedicines/en/.

Rausch M, Lorch S, Chung K, Frederick M, Zhang J, Barnhart K. A cost- effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertil Steril. 2012;97(2):355-60.

Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynaecologic indications. Int J Gynecol Obstet. 2013;121(2):186-9.

Kong G, Lok I, Yiu A, Hui A, Lai B, Chung T. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2013;53(2):170-7.

Shokry M, Fathalla M, Hussien M, Ashraf AE. Vaginal misoprostol versus vaginal surgical evacuation of first trimester incomplete abortion: Comparative study. Middle East Fertil Soc J. 2014;19(2):96-101.

Molnar AM, Oliver LM, Geyman JP. Patient preferences for management of first-trimester incomplete spontaneous abortion. J Am Board Fam Pract. 200;13(5):333-7.

Prasad S, Kumar A, Divya A. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation. Fertil Steril. 2009;91(1):28-31.

Ankum WM, Wieringa-De Waard M, Bindels PJ. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ. 2001;322(7298):1343-6.

Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006;332(7552):1235-40.

Lemmers M, Verschoor MA, Oude Rengerink K, Naaktgeboren C, Opmeer BC, Bossuyt PM, et al. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Hum Reprod. 2016;31(11):2421-7.

Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Mühlbacher, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3-13.